Rituximab for the treatment of type II mixed cryoglobulinemia.
Zaja
Francesco
F
De Vita
Salvatore
S
Russo
Domenico
D
Michelutti
Angela
A
Fanin
Renato
R
Ferraccioli
Gianfranco
G
Baccarani
Michele
M
D000368:Aged; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D003449:Cryoglobulinemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006526:Hepatitis C / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012217:Rheumatoid Factor / Q000097:blood; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007075:Immunoglobulin M; D000069283:Rituximab; D012217:Rheumatoid Factor